XWAR
MDG
Market cap63mUSD
Oct 09, Last price
25.00PLN
1D
-0.40%
1Q
-9.75%
Jan 2017
-91.88%
IPO
19.05%
Name
Medicalgorithmics SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2005 and headquartered in Warsaw, Poland, Medicalgorithmics S.A. is a prominent provider of cardiac diagnostic solutions, serving markets in Poland, the United States, and globally. The company offers an array of advanced products, including PocketECG, a comprehensive diagnostic system for arrhythmia detection that furnishes detailed ECG signals, data analysis, and exhaustive reports. Another key offering is PocketECG CRS, specifically designed for monitoring patients during cardiac rehabilitation. Its technological portfolio also encompasses ECG TechBot, a software program that utilizes algorithms for the automated analysis and interpretation of ECG signals, and PatchECG, a device enabling single-channel, offline heart monitoring. Additionally, PocketECG IV enhances the core PocketECG device by enabling continuous ECG signal transmission via LTE connectivity. Beyond its innovative devices, Medicalgorithmics S.A. delivers services in information technology, biotechnology, ECG monitoring, and scientific research and development, alongside manufacturing and distributing electro-medical equipment.
Key people
Krzysztof Siemionow
President of the Management Board, Chief Executive Officer · since 2025
Vice Chairman of the Supervisory Board · since 2021
Przemyslaw Tadla
Chief Technology Officer · since 2025
Chief Financial Officer, Member of the Management Board · since 2021
Jaroslaw Jerzakowski
Member of the Management Board · since 2021
Michal Zapora
Chief Financial Officer, Member of the Management Board · since 2025
Michal Zoltowski
Chairman of the Supervisory Board
Independent Member of the Supervisory Board · since 2018
Werner Engelhardt
Member of the Supervisory Board · since 2021
Pawel Lewicki
Member of the Supervisory Board
Independent Member of the Supervisory Board · since 2015
Mariusz Matuszewski
Independent Member of the Supervisory Board · since 2019
Marzena Piszczek
Member of the Supervisory Board
Member of the Supervisory Board · since 2021
Brandon Von Tobel
Member of the Supervisory Board · since 2021
Headquarters & legal address
WARSZAWA AL. JEROZOLIMSKIE 81
WARSZAWA, 14 02-001
PL
WARSZAWA, 14 02-001
PL
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||